Tokyo, April 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061401) titled 'Evaluation of the Utility of a Novel Nucleosome Biomarker Associated with Neutrophil Extracellular Traps' on April 28.
Study Type:
Observational
Primary Sponsor:
Institute - Hokkaido University
Condition:
Condition - ANCA-associated vasculitis, Antiphospholipid syndrome, Sepsis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To measure plasma levels of nucleosomes that may reflect neutrophil extracellular trap (NET) formation and to evaluate their utility as NETs markers by comparison with the representative NETs marker, the MPO-DNA complex.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients diagnosed with ANCA-associated vasculitis, anti- phospholipid syndrome, or sepsis.
Healthy adult volunteers
Key exclusion criteria - N/A
Target Size - 40
Recruitment Status:
Recruitment status - Main results already published
Date of protocol fixation - 2024 Year 11 Month 01 Day
Date of IRB - 2027 Year 04 Month 01 Day
Anticipated trial start date - 2024 Year 11 Month 13 Day
Last follow-up date - 2025 Year 07 Month 03 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070257
Disclaimer: Curated by HT Syndication.
